Diosynvax Ltd.

Research and experimental development on biotechnology · Hertford

ActiveUnited KingdomIncorporated 2017Private Limited Company

Financial position

Accounts to 2024-12-31 · GBP · unknown scope

Net assets

—

Cash

£2,143,051

Turnover

—

Profit / loss

—

Current assets

£2,188,592

Creditors < 1 year

—

Equity

£2,079,792

Average employees

GBP · unknown

Two periods with a known, matching scope are needed for a trend.

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

7 periods

Reported figures	2024-12-31GBP · unknown	2023-12-31GBP · unknown	2022-12-31GBP · unknown	2021-12-31GBP · unknown	2020-12-31GBP · unknown	2019-07-31GBP · unknown	2018-07-31GBP · unknown
Balance sheet
Equity	£2,079,792	£3,434,632	£4,320,996	£708,842	£1,120,142	−£5,001	−£380
Assets
Fixed assets	£430,139	£460,783	£266,607	£255,948	£166,860	£385	—
Intangible assets	£356,854	£378,483	£182,613	£170,721	£75,635	£385	£429
Property, plant & equipment	£73,285	£82,300	£83,994	£85,227	£91,225	£0	—
Current assets	£2,188,592	£3,653,903	£6,486,607	£559,471	£986,716	£55,506	£4,331
Cash at bank	£2,143,051	£2,867,828	£6,179,760	£403,887	£619,680	£43,500	£4,331
Debtors	£45,541	£786,075	£306,847	£155,584	£367,036	£12,006	£0
Liabilities
Net current assets	£1,649,653	£2,973,849	£4,054,389	£452,894	£953,282	−£5,386	−£809
Assets less current liabilities	£2,079,792	£3,434,632	£4,320,996	£708,842	£1,120,142	−£5,001	−£380
People
Average employees	13	10	7	7	7	1	1
Source evidence	View filing	View filing	View filing	View filing	View filing	View filing	View filing

Registered charges, lenders and security interests.

1 outstanding charges

Floating · created 2026-02-02

—

Outstanding